DK1809602T3 - Indolderivater, der kan anvendes som progesteronreceptormodulatorer - Google Patents
Indolderivater, der kan anvendes som progesteronreceptormodulatorerInfo
- Publication number
- DK1809602T3 DK1809602T3 DK05816083T DK05816083T DK1809602T3 DK 1809602 T3 DK1809602 T3 DK 1809602T3 DK 05816083 T DK05816083 T DK 05816083T DK 05816083 T DK05816083 T DK 05816083T DK 1809602 T3 DK1809602 T3 DK 1809602T3
- Authority
- DK
- Denmark
- Prior art keywords
- progesterone receptor
- indole derivatives
- prevention
- treatment
- receptor modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62258204P | 2004-10-27 | 2004-10-27 | |
| PCT/US2005/037817 WO2006049889A1 (en) | 2004-10-27 | 2005-10-21 | Indole derivatives useful as progesterone receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1809602T3 true DK1809602T3 (da) | 2009-02-16 |
Family
ID=35735187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05816083T DK1809602T3 (da) | 2004-10-27 | 2005-10-21 | Indolderivater, der kan anvendes som progesteronreceptormodulatorer |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7183309B2 (da) |
| EP (1) | EP1809602B1 (da) |
| JP (1) | JP5190268B2 (da) |
| CN (1) | CN101087758B (da) |
| AT (1) | ATE412631T1 (da) |
| AU (1) | AU2005302706B2 (da) |
| CA (1) | CA2585334C (da) |
| CY (1) | CY1109919T1 (da) |
| DE (1) | DE602005010734D1 (da) |
| DK (1) | DK1809602T3 (da) |
| ES (1) | ES2314739T3 (da) |
| PL (1) | PL1809602T3 (da) |
| PT (1) | PT1809602E (da) |
| SI (1) | SI1809602T1 (da) |
| WO (1) | WO2006049889A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4912414B2 (ja) | 2006-01-24 | 2012-04-11 | イーライ リリー アンド カンパニー | インドールスルホンアミド系のプロゲステロン受容体調節物質 |
| PL2148681T3 (pl) * | 2007-04-20 | 2016-09-30 | Selektywny modulator progesteronu w leczeniu krwawienia z macicy | |
| CN111153849B (zh) * | 2019-12-19 | 2021-03-26 | 南京林业大学 | 一种2-吲哚甲醇在水相反应体系中合成c3位硫醚化吲哚衍生物的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5081138A (en) * | 1986-12-17 | 1992-01-14 | Merck Frosst Canada, Inc. | 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith |
| US5851247A (en) * | 1997-02-24 | 1998-12-22 | Minnesota Mining & Manufacturing Company | Structured abrasive article adapted to abrade a mild steel workpiece |
| UA68365C2 (en) * | 1997-11-06 | 2004-08-16 | Wyeth Corp | Peroral contraception by combination of anti-estrogen and progestin |
| CA2322163A1 (en) | 1998-02-25 | 1999-09-02 | John Mckew | Inhibitors of phospholipase a2 |
| US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
| US6710068B2 (en) * | 2001-04-11 | 2004-03-23 | Idenix Pharmaceuticals, Inc. | Phenylindoles for the treatment of HIV |
| SE0201635D0 (sv) * | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| SE0202241D0 (sv) * | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
-
2005
- 2005-10-21 EP EP05816083A patent/EP1809602B1/en not_active Not-in-force
- 2005-10-21 JP JP2007538996A patent/JP5190268B2/ja not_active Expired - Fee Related
- 2005-10-21 DK DK05816083T patent/DK1809602T3/da active
- 2005-10-21 AU AU2005302706A patent/AU2005302706B2/en not_active Ceased
- 2005-10-21 SI SI200530551T patent/SI1809602T1/sl unknown
- 2005-10-21 AT AT05816083T patent/ATE412631T1/de active
- 2005-10-21 ES ES05816083T patent/ES2314739T3/es active Active
- 2005-10-21 CN CN2005800446115A patent/CN101087758B/zh not_active Expired - Fee Related
- 2005-10-21 WO PCT/US2005/037817 patent/WO2006049889A1/en active Application Filing
- 2005-10-21 CA CA2585334A patent/CA2585334C/en not_active Expired - Fee Related
- 2005-10-21 US US11/255,444 patent/US7183309B2/en not_active Expired - Fee Related
- 2005-10-21 PL PL05816083T patent/PL1809602T3/pl unknown
- 2005-10-21 DE DE602005010734T patent/DE602005010734D1/de active Active
- 2005-10-21 PT PT05816083T patent/PT1809602E/pt unknown
-
2007
- 2007-01-16 US US11/623,376 patent/US7345084B2/en not_active Expired - Fee Related
-
2009
- 2009-01-27 CY CY20091100097T patent/CY1109919T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1809602T1 (sl) | 2009-04-30 |
| CN101087758B (zh) | 2012-06-06 |
| CA2585334C (en) | 2014-05-13 |
| US20060111427A1 (en) | 2006-05-25 |
| EP1809602A1 (en) | 2007-07-25 |
| DE602005010734D1 (de) | 2008-12-11 |
| US20070135511A1 (en) | 2007-06-14 |
| CA2585334A1 (en) | 2006-05-11 |
| AU2005302706A1 (en) | 2006-05-11 |
| JP5190268B2 (ja) | 2013-04-24 |
| ATE412631T1 (de) | 2008-11-15 |
| US7345084B2 (en) | 2008-03-18 |
| ES2314739T3 (es) | 2009-03-16 |
| WO2006049889A1 (en) | 2006-05-11 |
| EP1809602B1 (en) | 2008-10-29 |
| JP2008518009A (ja) | 2008-05-29 |
| PT1809602E (pt) | 2008-12-15 |
| AU2005302706B2 (en) | 2011-12-15 |
| PL1809602T3 (pl) | 2009-04-30 |
| US7183309B2 (en) | 2007-02-27 |
| CY1109919T1 (el) | 2014-09-10 |
| CN101087758A (zh) | 2007-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005019905D1 (de) | -modulatoren | |
| CY1118407T1 (el) | Αντισωματα εξουδετερωσης υποδοχεα προλακτινης και θεραπευτικη χρηση αυτων | |
| ECSP18047708A (es) | Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo como antagonistas de progesterona y procedimientos para su preparación | |
| ATE366721T1 (de) | Indolinderivate als progesteron antagonisten | |
| NO20083523L (no) | Sammensetning for vaginal anvendelse | |
| DE602006013114D1 (de) | Mikronisiertes tanaproget und zusammensetzungen damit | |
| BR0316843A (pt) | Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio | |
| PL1874278T3 (pl) | Kompozycje zawierające mikronizowany tanaproget | |
| TR200103285T2 (tr) | Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri. | |
| DK1809602T3 (da) | Indolderivater, der kan anvendes som progesteronreceptormodulatorer | |
| CY1121190T1 (el) | Δοσολογικη μορφη ανταγωνιστη υποδοχεα προγεστερονης | |
| EA200702604A1 (ru) | Производные бензофуранона как нестероидные модуляторы рецептора прогестерона | |
| EA201792524A1 (ru) | Режим приема селективного модулятора рецептора прогестерона (sprm) | |
| ATE275973T1 (de) | Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten | |
| EA200702524A1 (ru) | Нестероидные модуляторы рецептора прогестерона | |
| MA32477B1 (fr) | Derives estratrienes comprenant des bioisosteres heterocycliques pour le cycle a phenolique | |
| CL2003001544A1 (es) | Compuestos derivados de 5-cicloalquenil-5h-cromeno[3,4-f]quinolina de formula i, moduladores selectivos del receptor de progesterona; composicion farmaceutica; y su uso en el tratamiento de sangrado uterino disfuncional, dismenorrea, endometriosis, l | |
| WO2008109055A3 (en) | Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor | |
| AR023854A1 (es) | Uso de derivados de indolina y equipo farmaceutico para regimenes ciclicos | |
| CY1113127T1 (el) | Οξα στεροειδη παραγωγα ως εκλεκτικοι τροποποιητες υποδοχεων προγεστερονης | |
| AR024549A1 (es) | Uso de moduladores de progesterona del receptor de progesterona y kit farmaceutica para regimenes ciclicos |